Aethlon Medical (AEMD) EPS (Weighted Average and Diluted) (2021 - 2023)
Historic EPS (Weighted Average and Diluted) for Aethlon Medical (AEMD) over the last 4 years, with Q1 2023 value amounting to -$1.21.
- Aethlon Medical's EPS (Weighted Average and Diluted) fell 37031.63% to -$1.21 in Q1 2023 from the same period last year, while for Dec 2023 it was -$0.98, marking a year-over-year increase of 8198.06%. This contributed to the annual value of -$8.58 for FY2025, which is 7792.5% up from last year.
- Latest data reveals that Aethlon Medical reported EPS (Weighted Average and Diluted) of -$1.21 as of Q1 2023, which was down 37031.63% from -$1.24 recorded in Q4 2022.
- Aethlon Medical's 5-year EPS (Weighted Average and Diluted) high stood at -$0.13 for Q3 2021, and its period low was -$1.84 during Q3 2022.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.64, with a median of -$0.21 in 2022.
- Over the last 5 years, Aethlon Medical's EPS (Weighted Average and Diluted) had its largest YoY gain of 1540.76% in 2022, and its largest YoY loss of 131180.64% in 2022.
- Quarter analysis of 3 years shows Aethlon Medical's EPS (Weighted Average and Diluted) stood at -$0.16 in 2021, then tumbled by 676.2% to -$1.24 in 2022, then rose by 2.85% to -$1.21 in 2023.
- Its EPS (Weighted Average and Diluted) stands at -$1.21 for Q1 2023, versus -$1.24 for Q4 2022 and -$1.84 for Q3 2022.